Vascular Endothelial Growth Factor in Patients with Exudative Age-related Macular Degeneration Treated with Ranibizumab
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference10 articles.
1. Ranibizumab and bevacizumab for neovascular age-related macular degeneration;Martin;N Engl J Med,2011
2. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab;Funk;Ophthalmology,2009
3. Pharmacokinetics of intravitreal ranibizumab (Lucentis);Bakri;Ophthalmology,2007
4. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients;Funatsu;Graefes Arch Clin Exp Ophthalmol,2005
5. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion;Noma;Eye (Lond),2008
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aqueous Humor Cytokine Analysis in Age-Related Macular Degeneration After Switching From Aflibercept to Faricimab;Investigative Ophthalmology & Visual Science;2024-09-09
2. Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway Trial;Ophthalmology Retina;2024-06
3. Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes;BMC Ophthalmology;2024-03-13
4. Long-Term Outcomes of Anti-VEGF Therapy with and without Posterior Scleral Reinforcement on Myopic Maculopathy in mCNV Eyes;2023-08-02
5. Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose;Pharmaceutics;2023-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3